Physics / mechanism
Health Care Equipment spans capital-intensive devices used in diagnostics, imaging, therapeutic delivery, monitoring, and surgical systems. Scope runs from MRI/CT gantries and ultrasound transducers through implantables, point-of-care diagnostics, and robotic surgery platforms. Global market ~$550B (2024), growing ~5–6% CAGR. Key players: Medtronic, Siemens Healthineers, GE HealthCare, Philips, Abbott. Performance parameters vary by segment: MRI spatial resolution sub-millimetre, CT dose <10 mSv, PCR sensitivity to single-copy nucleic acids. The frontier is semiconductor content density — photonic sensors, MEMS transducers, ASICs for signal processing, and SiC/GaN power stages — driving miniaturisation and home-shift of diagnostics.
Competitive landscape
Competing approaches include pharmaceutical substitution (drugs displacing devices in metabolic disease), software-only digital therapeutics, and AI diagnostic layers that extract value from existing hardware without new capital equipment. Adjacent segments: in-vitro diagnostics (IVD), medical imaging software, wearables/continuous monitoring. Traditional OEM hardware faces margin pressure from platform-as-a-service models (outcomes-based contracts). Key substitution threat is consumer-grade sensing (Apple Watch ECG, CGM commoditisation) collapsing clinical-grade premium positioning in select categories.
| Segment | Margin profile | Semi intensity |
|---|---|---|
| Capital imaging (MRI/CT) | High ASP, low volume | Moderate (RF coils, power) |
| Point-of-care diagnostics | Razor/blade, volume | High (ASICs, photonics) |
| Wearable monitoring | Thin margin, scale | Very high (SoC, sensors) |
Companies using
Connected ideas
Sources
Frontier (open questions)
- To be added.